Omicron 5 times more likely to reinfect than Delta, no less severe: study – National | Globalnews.ca

The risk of reinfection with the Omicron coronavirus variant is more than five times higher and it has
shown no sign of being milder than Delta, a study by Imperial College London showed, as cases soar across Europe and threaten year-end festivities.

The results were based on UK Health Security Agency and National Health Service data on people who tested positive for COVID-19 in a PCR test in England between Nov. 29 and Dec. 11.

“We find no evidence (for both risk of hospitalization attendance and symptom status) of Omicron having different severity from Delta,” the study said, although it noted that data on hospitalizations remains very limited.

Read more:

Omicron FAQ: Everything you need to know about the COVID-19 variant

“Controlling for vaccine status, age, sex, ethnicity, asymptomatic status, region and specimen date, Omicron was associated with a 5.4-fold higher risk of reinfection compared with Delta,” the study, which was dated Dec. 16, added.

Story continues below advertisement

“This implies that the protection against reinfection by Omicron afforded by past infection may be as low as 19 per cent,” Imperial College added in a statement, noting that the study had not yet been peer reviewed.


Click to play video: 'COVID-19: Canada’s top doctor says ‘we mustn’t dismiss’ Omicron in terms of case severity'







COVID-19: Canada’s top doctor says ‘we mustn’t dismiss’ Omicron in terms of case severity


COVID-19: Canada’s top doctor says ‘we mustn’t dismiss’ Omicron in terms of case severity

 

An earlier study by Britain’s SIREN looking at reinfection risk in health workers, which was carried out before Omicron emerged, found that a first coronavirus infection offered 85 per cent protection from a second for the following six months.

The data analysed by Imperial College was based on 333,000 cases, including 122,062 of Delta and 1,846 which were confirmed as the Omicron coronavirus variant through genome sequencing.

The new findings could accelerate the imposition of tighter restrictions across a number of European countries in a bid to stem the new variant’s spread.

Story continues below advertisement

(Reporting by Clara-Laeila Laudette; Editing by Alexander Smith)

View link »





For all the latest health News Click Here 

Read original article here

Denial of responsibility! TechAI is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.